# HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass Surgery

> **NCT07646210** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **HELP Therapeutics Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Advanced Heart Failure
- Ischemic Heart Failure

## Interventions

- **DRUG:** HiCM-188 Cells

## Key facts

- **NCT ID:** NCT07646210
- **Lead sponsor:** HELP Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646210, "HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07646210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*